Jeffrey E. Russel

Array ( [id] => 3656878 [patent_doc_number] => 05656294 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Colonic delivery of drugs' [patent_app_type] => 1 [patent_app_number] => 8/486974 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6884 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656294.pdf [firstpage_image] =>[orig_patent_app_number] => 486974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3772560 [patent_doc_number] => 05849866 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Peptidase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/481666 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24231 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849866.pdf [firstpage_image] =>[orig_patent_app_number] => 481666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771976 [patent_doc_number] => 05773581 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Conjugate of a solution stable G-CSF derivative and a water-soluble polymer' [patent_app_type] => 1 [patent_app_number] => 8/488457 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 53319 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773581.pdf [firstpage_image] =>[orig_patent_app_number] => 488457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3807672 [patent_doc_number] => 05854215 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Modulators of .beta.-amyloid peptide aggregation' [patent_app_type] => 1 [patent_app_number] => 8/475579 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12055 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/854/05854215.pdf [firstpage_image] =>[orig_patent_app_number] => 475579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3608756 [patent_doc_number] => 05589463 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'Oral delivery of biologically active substances bound to vitamin B12' [patent_app_type] => 1 [patent_app_number] => 8/479635 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4296 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589463.pdf [firstpage_image] =>[orig_patent_app_number] => 479635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3772518 [patent_doc_number] => 05807832 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Oral delivery of biologically active substances bound to vitamin B.sub.12' [patent_app_type] => 1 [patent_app_number] => 8/483811 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4321 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807832.pdf [firstpage_image] =>[orig_patent_app_number] => 483811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3728192 [patent_doc_number] => 05700904 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-23 [patent_title] => 'Preparation of an acylated protein powder' [patent_app_type] => 1 [patent_app_number] => 8/484220 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4731 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/700/05700904.pdf [firstpage_image] =>[orig_patent_app_number] => 484220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1361809 [patent_doc_number] => 06565842 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Crosslinkable polypeptide compositions' [patent_app_type] => B1 [patent_app_number] => 08/484724 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13422 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/565/06565842.pdf [firstpage_image] =>[orig_patent_app_number] => 08484724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3549475 [patent_doc_number] => 05518706 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-21 [patent_title] => 'Basic aluminum chlorosulfate flocculant' [patent_app_type] => 1 [patent_app_number] => 8/485505 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6643 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/518/05518706.pdf [firstpage_image] =>[orig_patent_app_number] => 485505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3808824 [patent_doc_number] => 05811391 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Cyclic CS-1 peptidomimetics, compositions and methods of using same' [patent_app_type] => 1 [patent_app_number] => 8/483077 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 16531 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811391.pdf [firstpage_image] =>[orig_patent_app_number] => 483077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3820534 [patent_doc_number] => 05730969 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-24 [patent_title] => 'Method and compositions for solubilization and stabilization of polypeptides, especially proteins' [patent_app_type] => 1 [patent_app_number] => 8/474178 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12077 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/730/05730969.pdf [firstpage_image] =>[orig_patent_app_number] => 474178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775293 [patent_doc_number] => 05808010 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Method for derivatization of cellulosic stationary phase' [patent_app_type] => 1 [patent_app_number] => 8/485839 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5980 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/808/05808010.pdf [firstpage_image] =>[orig_patent_app_number] => 485839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3833100 [patent_doc_number] => 05814602 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Heparin-binding proteins' [patent_app_type] => 1 [patent_app_number] => 8/470841 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8719 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814602.pdf [firstpage_image] =>[orig_patent_app_number] => 470841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3769854 [patent_doc_number] => 05849689 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Method of extending the plasma half-life of deletion variants of hepatocyte growth factor' [patent_app_type] => 1 [patent_app_number] => 8/466326 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 12278 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849689.pdf [firstpage_image] =>[orig_patent_app_number] => 466326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3827715 [patent_doc_number] => 05759997 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Cyclosporin galenic forms' [patent_app_type] => 1 [patent_app_number] => 8/471301 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14335 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/759/05759997.pdf [firstpage_image] =>[orig_patent_app_number] => 471301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3850614 [patent_doc_number] => 05767085 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Compounds with growth hormone releasing properties' [patent_app_type] => 1 [patent_app_number] => 8/448623 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11985 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 654 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767085.pdf [firstpage_image] =>[orig_patent_app_number] => 448623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3728746 [patent_doc_number] => 05652212 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Cyclosporin galenic forms' [patent_app_type] => 1 [patent_app_number] => 8/471302 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14333 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652212.pdf [firstpage_image] =>[orig_patent_app_number] => 471302 [rel_patent_id] =>[rel_patent_doc_number] =>)